Syncom Formulation (India) Share Price
₹20.49 -0.63 (-2.98%)
22 Dec, 2024 21:27
Start SIP in SYNCOMF
Start SIPPerformance
- Low
- ₹20
- High
- ₹21
- 52 Week Low
- ₹11
- 52 Week High
- ₹28
- Open Price₹21
- Previous Close₹21
- Volume3,072,767
Investment Returns
- Over 1 Month + 3.9%
- Over 3 Month -9.82%
- Over 6 Month + 61.72%
- Over 1 Year + 76.18%
Smart Investing Starts Here Start SIP with Syncom Formulation (India) for Steady Growth!
Syncom Formulation (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 58.1
- PEG Ratio
- 1.4
- Market Cap Cr
- 1,926
- P/B Ratio
- 6.7
- Average True Range
- 0.91
- EPS
- 0.35
- Dividend Yield
- 0
- MACD Signal
- 0.34
- RSI
- 42.56
- MFI
- 45.5
Syncom Formulation (India) Financials
Syncom Formulation (India) Technicals
EMA & SMA
Current Price
₹20.49
-0.63
(-2.98%)
- Bullish Moving Average 0
- Bearish Moving Average 0
- 20 Day
- ₹21.35
- 50 Day
- ₹20.94
- 100 Day
- ₹19.85
- 200 Day
- ₹17.71
Resistance and Support
20.69
- R3 22.10
- R2 21.72
- R1 21.07
- S1 20.04
- S2 19.66
- S3 19.01
Syncom Formulation (India) Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-11 | Quarterly Results | |
2024-08-12 | Quarterly Results | |
2024-05-17 | Audited Results | |
2024-02-14 | Quarterly Results | |
2023-11-08 | Quarterly Results |
Syncom Formulation (India) F&O
About Syncom Formulation (India)
- NSE Symbol
- SYNCOMF
- BSE Symbol
- 524470
- Managing Director
- Mr. Vijay Shankarlal Bankda
- ISIN
- INE312C01025
Similar Stocks to Syncom Formulation (India)
Syncom Formulation (India) FAQs
Syncom Formulation (India) share price is ₹20 As on 22 December, 2024 | 21:13
The Market Cap of Syncom Formulation (India) is ₹1926.1 Cr As on 22 December, 2024 | 21:13
The P/E ratio of Syncom Formulation (India) is 58.1 As on 22 December, 2024 | 21:13
The PB ratio of Syncom Formulation (India) is 6.7 As on 22 December, 2024 | 21:13
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.